Why Is Colonoscopy-Focused Motus GI Stock Trading Higher Today?

Motus GI Holdings Inc MOTS shares are trading higher on Wednesday, trading on a strong session volume of 45.51 million compared to the average volume of 563.313K, as per data from Benzinga Pro.

The medical technology company focused on improving endoscopic outcomes and experiences, announced that the United States Patent and Trademark Office (USPTO) has issued the company a new patent (patent # 11904085) titled, “Colon Cleaning System with Automatic Self-Purging Feature.”

The company says this latest patent covers the automated management of pressure for irrigation and the self-purging feature of the latest generation of the Pure-Vu system.

The new patent covers systems and methods for cleaning a colon or other portion of the GI tract, including the optional use of sensors to detect conditions of blockage of the flow of materials within an evacuation channel used to remove debris from the body; and devices and methods for purging such blockages from the evacuation channel. 

This latest patent application is a continuation of U.S. patent applications Ser. No. 16/389,955 filed on April 21, 2019.

Inpatient endoscopy on patients admitted to the hospital can be challenging to get a quality procedure promptly due to GI tract debris. 

According to the literature, up to 50% of inpatient colonoscopies can have an extra night of hospitalization due to inadequate preparation, and market research has shown that 30% of upper GI bleed cases have issues with adequate visualization, affecting the length and outcome of the procedure.

Price Action: MOTS shares are up 62.50% at $1.06 on the last check Wednesday.